BLDE SCHEDULE 13D: Activist campaign
Third Point LLC and Daniel S. Loeb
Filed with the SEC on · accession 0000899140-26-001108
BLDE filed a SCHEDULE 13D (schedule 13d) with the SEC on Oct 15, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
Third Point LLC and Daniel S. Loeb filed a joint Schedule 13D reporting a position in Strata Critical Medical, Inc. common stock, indicating a potential activist stake.
Key details
✦ Ask GOAX AI about this filing — what it means for BLDE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BLDE?
Click hereFrequently asked questions
What did BLDE file with the SEC on Oct 15, 2026?
BLDE filed a SCHEDULE 13D (Activist campaign). Third Point LLC and Daniel S. Loeb filed a joint Schedule 13D reporting a position in Strata Critical Medical, Inc. common stock, indicating a potential activist stake.
What does a activist campaign mean for BLDE stock?
A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.
How do I read a SCHEDULE 13D?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).
Other BLDE SEC filings
Get alerts when BLDE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days